Calt Bio logo

  • Home

  • Walk into Kachiu

    • Company Profile

    • Corporate Culture

    • Development History

  • Blog

    • Corporate News

    • Industry News

    • Knowledge Lecture Hall

  • Product Center

    • Immunohistochemistry Immunohistochemistry

    • Companion Diagnostics Companion Diagnostics

    • Molecular Pathology Molecular Pathology

    • Early Cancer Screening

    • Liquid-based cytology

    • Special Staining

  • Technology Platform

    • Antibody Technology Platform

    • Secondary Antibody Technology Platform

    • Molecular Technology Platform

    • Intelligent Digital Equipment Technology Platform

  • Solution

    • Development and application of companion diagnostic reagents

    • Comprehensive Immunohistochemistry Solutions

  • Contact Us

    • Contact Information

    • Online Message

  • Recruiting Talents

    • Campus Recruitment

    • Social Recruitment

img
img
img 微信公众号

CN  /  EN

All
  • All
  • Product Management
  • News & Information
  • Introduction Content
  • Company Outlets
  • FAQ
  • Company Video
  • Company Album
News Center

News Center

News Center

News Center

2024-03-02

Tight junction protein family: claudin-4

Tight junction protein family: claudin-4

Learn More Details

2024-02-29

A case report of a difficult case involving autoimmune gastritis, well-differentiated neuroendocrine tumor, and mixed fundic gland-type adenocarcinoma

A case report of a difficult case involving autoimmune gastritis, well-differentiated neuroendocrine tumor, and mixed fundic gland-type adenocarcinoma

Learn More Details

2024-02-29

Highly anticipated target, TIGIT

Highly anticipated target, TIGIT

Learn More Details

2024-02-02

2024, the dragon moves majestically, setting sail again to brave the winds and waves!!!

2024, the dragon moves majestically, setting sail again to brave the winds and waves!!!

Learn More Details

2024-02-02

Past star, the first immune checkpoint CTLA-4

Past star, the first immune checkpoint CTLA-4

Learn More Details

2024-02-02

Further discussion on CLDN18.2, the first targeted drug is expected to be launched

Further discussion on CLDN18.2, the first targeted drug is expected to be launched

Learn More Details
< 1...101112...27 >
  • Home

  • Walk into Kachiu

    • Company Profile

    • Corporate Culture

    • Development History

  • Blog

    • Corporate News

    • Industry News

    • Knowledge Lecture Hall

  • Product Center

    • Immunohistochemistry

    • Companion Diagnostics

    • Molecular Pathology

    • Early Cancer Screening

    • Liquid-based cytology

    • Special Staining

  • Technology Platform

    • Antibody Technology Platform

    • Secondary Antibody Technology Platform

    • Molecular Technology Platform

    • Intelligent Digital Equipment Technology Platform

  • Solution

    • Development and application of companion diagnostic reagents

    • Comprehensive Immunohistochemistry Solutions

  • Contact Us

    • Contact Information

    • Online Message

  • Recruiting Talents

    • Campus Recruitment

    • Social Recruitment

Follow Us

Image Name

Scan

Follow Us

Search "Calt Bio" on WeChat

National Unified Service Hotline

400-000-8876

Copyright © 2024 Calt (Jiangsu) Biotechnology Co., Ltd.

Website Construction:www.300.cn Nanjing SEO

Business License

Sorry,There is currently no content in the current column!

You can check other sections or return Home

Sorry,The current column has no content!

You can view other columns or return Home